Galaxy银河|澳门官网·登录入口

至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

The application of the CRISPR-Cas9 system in Pseudomonas syringae pv actinidiae

J Med Microbiol. 2020; 
Ho J, Zhao M, Wojcik S, Taiaroa G, Butler M, Poulter R.
Products/Services Used Details Operation
Gene Synthesis … The GC composition was measured using Geneious 1103 [39] and the codon usage optimized for E coli The revised sequence, flanked by NdeI sites, was synthesized and cloned into the vector pUC57-Kan by Genscript Get A Quote

摘要

Introduction . Pseudomonas syringae pv. actinidiae (Psa) has emerged as a major bacterial pathogen of kiwifruit cultivation throughout the world.Aim . We aim to introduce a CRISPR-Cas9 system, a commonly used genome editing tool, into Psa. The protocols may also be useful in other Pseudomonas species.Methodology . Using standard molecular biology techniques, we modified plasmid pCas9, which carries the CRISPR-Cas9 sequences from Streptococcus pyogenes, for use in Psa. The final plasmid, pJH1, was produced in a series of steps and is maintained with selection in both Escherichia coli and Psa.Results . We have constructed plasmids carrying a CRISPR-Cas9 system based on that of S. pyogenes, which can be maintained... More

关键词

XML 地图